Literature DB >> 11549932

Relationship between cannabis use, schizotypal traits, and cognitive function in healthy subjects.

R Mass1, C Bardong, K Kindl, B Dahme.   

Abstract

This research examined the relationship between cannabis use and schizotypal features. A sample of cannabis users (n = 20) was compared with a matched control group (n = 20). All participants were male students of the University of Hamburg. Subjects completed the Perceptual Aberration Scale and the Schizotypal Personality Questionnaire. A Negative Priming procedure and the Trail Making Test were carried out. A urine sample was obtained from each subject. Cannabis users exceeded controls in schizotypy scores and showed impaired neuropsychological parameters. Only within the cannabis group schizotypy scores correlated with neuropsychological parameters. Furthermore, cannabis users reported more often high-risk factors than controls. These findings indicate that among cannabis users there is an increased number of subjects with schizotypal features; schizotypal subjects seem to be more likely to use cannabis than the general population. Therefore, cannabis use may be a vulnerability indicator for schizophrenia. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2001        PMID: 11549932     DOI: 10.1159/000049309

Source DB:  PubMed          Journal:  Psychopathology        ISSN: 0254-4962            Impact factor:   1.944


  10 in total

1.  Association between cannabis use, psychosis, and schizotypal personality disorder: findings from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Glen P Davis; Michael T Compton; Shuai Wang; Frances R Levin; Carlos Blanco
Journal:  Schizophr Res       Date:  2013-11-05       Impact factor: 4.939

2.  Association of Schizotypy With Dimensions of Cognitive Control: A Meta-Analysis.

Authors:  Maria Steffens; Inga Meyhöfer; Kaja Fassbender; Ulrich Ettinger; Joseph Kambeitz
Journal:  Schizophr Bull       Date:  2018-10-15       Impact factor: 9.306

3.  Cannabis users differ from non-users on measures of personality and schizotypy.

Authors:  Daniel J Fridberg; Jennifer M Vollmer; Brian F O'Donnell; Patrick D Skosnik
Journal:  Psychiatry Res       Date:  2011-03-30       Impact factor: 3.222

4.  Hemispheric language asymmetry in first episode psychosis and schizotypy: the role of cannabis consumption and cognitive disorganization.

Authors:  Daniela A Herzig; Sarah Sullivan; Glyn Lewis; Rhiannon Corcoran; Richard Drake; Jonathan Evans; David Nutt; Christine Mohr
Journal:  Schizophr Bull       Date:  2014-12-27       Impact factor: 9.306

Review 5.  Role of endocannabinoid system in mental diseases.

Authors:  Jorge Manzanares; Leyre Urigüen; Gabriel Rubio; Tomás Palomo
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

6.  Prevalence, correlates, disability, and comorbidity of DSM-IV schizotypal personality disorder: results from the wave 2 national epidemiologic survey on alcohol and related conditions.

Authors:  Attila J Pulay; Frederick S Stinson; Deborah A Dawson; Risë B Goldstein; S Patricia Chou; Boji Huang; Tulshi D Saha; Sharon M Smith; Roger P Pickering; W June Ruan; Deborah S Hasin; Bridget F Grant
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009

7.  Associations between past alcohol, cannabis, and cocaine use and current schizotypy among first-degree relatives of patients with schizophrenia and non-psychiatric controls.

Authors:  Michael T Compton; Victoria H Chien; Annie M Bollini
Journal:  Psychiatr Q       Date:  2009-04-25

8.  Cannabinoid CB1 receptor-mediated impairment of visuospatial attention in the rat.

Authors:  P Alexander Arguello; J David Jentsch
Journal:  Psychopharmacology (Berl)       Date:  2004-07-29       Impact factor: 4.530

9.  Alcohol and Relatively Pure Cannabis Use, but Not Schizotypy, are Associated with Cognitive Attenuations.

Authors:  Daniela A Herzig; David J Nutt; Christine Mohr
Journal:  Front Psychiatry       Date:  2014-09-29       Impact factor: 4.157

10.  Personality Traits and Psychotic Proneness Among Chronic Synthetic Cannabinoid Users.

Authors:  Koby Cohen; Shiri Rosenzweig; Paola Rosca; Albert Pinhasov; Abraham Weizman; Aviv Weinstein
Journal:  Front Psychiatry       Date:  2020-05-15       Impact factor: 4.157

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.